Prøve GULL - Gratis
Preventing moisture vital to ensure product quality
Chronicle Pharmabiz
|July 24, 2025
THE primary purpose of packaging is to take a product to a customer without any quality degradation. Packaging plays many significant roles such as containing and protecting products during distribution, storage and use, while also promoting, educating and selling.
The most vital factor in maintaining the quality of pharmaceuticals throughout its shelf-life is the integrity of its packaging. Preventing moisture from permeating through the packaging is a significant function of the container-closure system used for pharmaceuticals.
Stability for all pharmaceuticals is associated with the availability of the active ingredient during the entire shelf-life, without the occurrence of any adverse event or reaction of degradation.
Package system must be chemically inert to avoid interactions between the medicines/products, packaging and the closure material (must avoid leachable or extractable materials). It should be an effective barrier against moisture and gases to protect the product and thus guarantee the efficacy of the medicine. A barrier material's design has a great impact on moisture vapour transmission rate.
Water vapour can readily move either from the inside of a package to the outside environment, or from the outside environment to the inside of the package. Either way it can impact the quality and shelf-life of a packaged product.
Moisture vapour transmission rate
Moisture vapour transmission rate also known as water vapour transmission rate, is the amount of water vapour that passes through a substance or a material over a specific period of time.
Water vapour transmission rate referred to alternatively as moisture vapour transmission rate, stands for the standard measure of the passing - permeation - of gaseous water through a substrate. It is the steady state rate at which gaseous water vapour passes through a substrate at specific temperature and relative humidity conditions over a peculiar period of time.
Denne historien er fra July 24, 2025-utgaven av Chronicle Pharmabiz.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Chronicle Pharmabiz
Chronicle Pharmabiz
Home-grown CAR-T cell therapies gaining ground
INDIAN biotech and pharmaceutical companies are actively working on innovative solutions to make CART cell therapy both accessible and cost-effective.
4 mins
November 27, 2025
Chronicle Pharmabiz
NPPA extends price fixation on orthopaedic implants for 1 year
IN a move that will disappoint the industry, the National Pharmaceutical Pricing Authority (NPPA) has extended the ceiling price fixation it imposed on orthopaedic knee implants for knee replacement system for one more year.
1 mins
November 27, 2025
Chronicle Pharmabiz
FICCI envisages it's Smart AAMs to boost healthcare
In line with the Central Government's vision of comprehensive primary healthcare, FICCI Swasth Bharat Task Force has undertaken a transformative initiative titled 'Smart Ayushman Arogya Mandirs-AAMs' (earlier called Health & Wellness Centres) aimed at strengthening the primary healthcare delivery system across India.
1 min
November 27, 2025
Chronicle Pharmabiz
DoP asked to bring policy for affordable drug pricing
THE Parliamentary Panel on Chemicals and Fertilisers has recommended to the Department of Pharmaceutical (DoP) to take steps to come out with a pharmaceutical policy with thrust to provide both scheduled and nonscheduled formulations at affordable prices.
1 mins
November 27, 2025
Chronicle Pharmabiz
Ramaiah emphasises need for bone health and osteoporosis diagnosis
RAMAIAH Memorial Hospital (RMH), a multi-superspecialty quaternary care hospitals emphasises on bone health and osteoporosis diagnosis. It calls for timely screening and diagnosis through the new and advanced DXA scanner with superior and accurate test results.
2 mins
November 27, 2025
Chronicle Pharmabiz
Nathealth calls for action in 2026-27 Union Budget
NATHEALTH has submitted its budget 2026-27 recommendations to the Union government, outlining a roadmap to strengthen healthcare delivery, foster innovation, and expand insurance and preventive coverage.
1 mins
November 27, 2025
Chronicle Pharmabiz
Hotspots & growth opportunities in biomanufacturing
THE Indian bioeconomy has grown from US$ 10 billion in 2014 to US$ 165.7 billion in 2024, and is likely reach US$ 300 billion by 2030.
3 mins
November 27, 2025
Chronicle Pharmabiz
Omega Hospitals acquires Cytecare Hospitals
Morgan Stanley PE backed Hyderabad-based Omega Hospitals has acquired Cytecare Hospitals, a leading cancer care hospital in Bengaluru.
2 mins
November 27, 2025
Chronicle Pharmabiz
Devices sector hails withdrawal of QCOs
THE medical devices manufacturers industry in the country has welcomed the Central government's decision to withdraw multiple Quality Control Orders (QCOs) imposed on essential raw materials across various industries, including the medical devices sector.
1 min
November 27, 2025
Chronicle Pharmabiz
'There is urgent need for tech-focused regulatory approach for med devices'
THE Indian healthcare industry has evolved at a breakneck pace, but its regulatory framework has struggled to keep up to its speed of development.
2 mins
November 27, 2025
Listen
Translate
Change font size
